https://www.selleckchem.com/pr....oducts/muvalaplin.ht
When combined with anti-PD-L1 antibody, the combined strategy not only inhibited the growth of primary tumor, but also significantly delayed the proliferation of the contralateral tumors. More importantly, this strategy reversed immunosuppressive microenvironment without obvious side effects. Therefore, this study provided a great immunotherapy platform for the efficient treatment of primary and metastatic tumors.Rapid endothelialization helps overcome the limitations of small-diameter vascular grafts. To develop biomimetic non-throm